why choose us

🌐 Go to WebHealthNetwork.com
Go to Consumers Chat
First received: May 30, 2025

Clinical Trial: Evaluation of the Efficacy and Safety of Eolo in Patients With NERD

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Non-erosive Reflux Disease

Study Type: INTERVENTIONAL


Official Title: Evaluation of the Efficacy and Safety of a Nutraceutical Containing Sodium Alginate, Sodium Bicarbonate, PEA, a Blend of Opuntia Ficus Indica, and Olea Europaea, Musa Paradisiaca, and Ginger in Patien

Brief Summary: Background: Non-erosive reflux disease (NERD) is a prevalent subtype of gastroesophageal reflux disease (GERD), often inadequately managed with proton pump inhibitors (PPIs) alone.Eolo, a nutraceutical blend of sodium alginate, sodium bicarbonate, palmitoylethanolamide (PEA), and herbal extracts, has been proposed as an adjunctive therapy to enhance symptom relief and mucosal protection.Objective: This study evaluates the efficacy and safety of a nutraceutical [Eolo®, Cristalfarma s.r.l. - Milan (IT)] in…

Read more